| 期刊論文| 1. | 施雅儀(20140900)。從美國Myriad案探討經分離DNA之專利適格性。智慧財產權月刊，189，48-69。 延伸查詢 | | 2. | Peden, Aude S.(20200730)。Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic。The National Review，10(212)。  | | 3. | Ravi, Srividya、Jadhav, Sammita、Vaidya, Anuradha、Ghooi, Ravindra(2021)。Repurposing Drugs during the COVID-19 Pandemic and Beyond。Pharmaceutical Patent Analyst，10(1)，9-12。 | | 4. | Mahn, Terry(2020)。COVID, Drug Pricing, and Patents。Life Science Leader magazine，2020(Dec.)。 | | 5. | Gaviria, Mario、Kilic, Burcu(20210512)。A Network Analysis of COVID-19 mRNA Vaccine Patents。Nature Biotechnology，39(5)，546-548。 | 研究報告| 1. | Correa, Carlos(2016)。Guidelines for Pharmaceutical Patent Examination: Examining Pharmaceutical Patents from a Public Health Perspective。UNDP。 | 其他| 1. | Merry, Robyn-Leigh(20201124)。COVID-19 and Intellectual Property's role in facilitating vaccine access，https://www.lexology.com/library/detail.aspx?g=56ebf600-3ab8-4a22-af99-1615f6b312cb。 | | 2. | Vázquez, Irene(20200220)。SARS-CoV-2 Coronavirus and patents，https://abg-ip.com/coronavirus-patents/。 | | 3. | Longsworth, Gaby L.，Sterne, Robert Greene(2020)。Patenting Compounds, Compositions, and Methods for Viral Infections，https://www.sternekessler.com/news-insights/publications/patenting-compounds-compositions-and-methods-viral-infections。 | | 4. | Hickey, Kevin J.，Shen, Wen W.，Ward, Erin H.(2020)。Legal Issues in COVID-19 Vaccine Development and Deployment，https://crsreports.congress.gov/product/pdf/R/R46399。 | | 5. | Hollman, Steven，Simeone, Calla(20200915)。Trade Secret Protection & The COVID-19 Cure: Observations on Federal Policy-Making & Potential Impact on Biomedical Advances，https://www.jdsupra.com/legalnews/trade-secret-protection-the-COVID-19-37383/。 | | 6. | Nikolai, James(2020)。COVID-19 Research: Will the Results be Patent Eligible?，https://www.dewittllp.com/news-education/posts/2020/05/21/covid-19-research-will-the-results-be-patent-eligible。 | | 7. | Moreira, Vitor S.(2021)。Drug Patent Applications to Combat COVID-19，https://inventa.com/en/news/article/591/drug-patent-applications-to-combat-covid-19。 | | 8. | Courage, Noel，Yacoob, Reza(2020)。The Race to Produce a COVID-19 Vaccine (Part I): Introduction to Vaccine Development & IP，https://www.bereskinparr.com/doc/the-race-to-produce-a-covid-19-vaccine-part-i-introduction-to-vaccine-development-ip。 | | 9. | Silbersher, Zachary(2020)。Which Patents Cover COVID-19 Vaccine Candidates for Moderna, AstraZeneca, J&J and Novovax?，https://www.markmanadvisors.com/blog/2020/7/21/which-patents-cover-the-covid-19-vaccine-candidates-for-moderna-astrazeneca-jampj-and-novovax。 | | 10. | Gaviria, Mario，Kilic, Burcu(2020)。BioNTech and Pfizer's BNT162 Vaccine Patent Landscape，https://www.citizen.org/article/biontech-and-pfizers-bnt162-vaccine-patent-landscape/。 | | 11. | Lowe, Derek(20200724)。Formulating RNA: And Owning It，https://blogs.sciencemag.org/pipeline/archives/2020/07/24/formulating-rna-and-owning-it。 | | 12. | Koenigbauer, Fabian(20201014)。Moderna Opens Its IP Vault During the Pandemic to Allow Others to Rely on Its Patented Technologies to Find a Treatment for COVID-19，https://www.jdsupra.com/legalnews/moderna-opens-its-ip-vault-during-the-25175/。 | | 13. | Shores, Dan(20201111)。Breaking Down Moderna's COVID-19 Patent Pledge: Why Did They Do It?，https://ipwatchdog.com/2020/11/11/breaking-modernas-COVID-19-patent-pledge/id=127224/。 | |